Subscribe to Newsletter

Martin VanTrieste


President and Chief Executive Officer at Civica Rx

Under VanTrieste’s leadership, Civica has expanded its membership to include more than 55 health systems representing over 1,500 hospitals across the US, and has delivered nearly 60 essential medications for hospitals, 11 of which are being used to treat COVID-19 patients. Most recently, Civica announced its plans to manufacture and distribute insulin that, once approved, will be available to people with diabetes at significantly lower prices than insulin currently on the market. The availability of affordable insulin will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.


Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register